Pfizer lung cancer drug beats chemo for previously untreated patients

[riky]

Pfizer lung cancer drug beats chemo for previously untreated patients

<p><a href="http://news.yahoo.com/pfizer-lung-cancer-drug-beats-chemo-previously-untreated-140258960--finance.html"><img src="http://l1.yimg.com/bt/api/res/1.2/uccDOQWm0kpXzyflPvIpWQ--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9NzU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2014-03-25T140258Z_1_CBREA2O131300_RTROPTP_2_PFIZER.JPG" width="130" height="86" alt="The Pfizer logo is seen outside their world headquarters in New York" align="left" title="The Pfizer logo is seen outside their world headquarters in New York" border="0" /></a>(Reuters) - Pfizer Inc's Xalkori delayed progression of lung cancer longer than chemotherapy in patients who had never previously been treated for the disease, according to results of a late-stage study released on Tuesday. The medicine, which received U.S. approval in 2011 for lung cancer patients who have a specific gene mutation, had shown in a previous Phase III trial that it significantly delayed disease progression among those who have already undergone chemotherapy for non-small-cell lung cancer, the most common form of the illness. Pfizer said favorable results from the latest trial, combined with those from the earlier big study, establish that Xalkori is appropriate for first-line as well as second-line use, meaning for patients receiving initial treatment as well as for those who have already undergone chemotherapy. The mutation only occurs in a small percentage of patients with lung cancer, but makes them good candidates for treatment with Xalkori.</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login